← Back to Search

Bone-patellar tendon-bone (BPTB) for Jumper's Knee

N/A
Recruiting
Led By Bryan Heiderscheit, PT, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 weeks
Awards & highlights
No Placebo-Only Group

Summary

The goal of this observational study is to understand how diffusion tensor imaging (DTI) relates to other traditional measures and knee function. The main question it aims to answer is: Will regions of known patellar tendon pathology present with smaller DTI scalar parameters, shorter fiber length, and lower fiber density compared to the contralateral tendon and healthy regions in the ipsilateral tendon. Participants will: * undergo MRI and ultrasound imaging * perform knee function test * complete questionnaires

Eligible Conditions
  • Jumper's Knee
  • Anterior Cruciate Ligament Reconstruction

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Compare DTI scalar parameters of known patellar tendon pathology to the healthy regions in the ipsilateral tendon
Compare scalar parameters of known patellar tendon pathology to the contralateral tendon

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Patellar tendinopathy groupExperimental Treatment2 Interventions
This group will have patellar tendinopathy confirmed based on International Scientific Tendinopathy Symposium Consensus on Clinical Terminology (ICON) statement, which defines patellar tendinopathy as "persistent patellar tendon pain and loss of function related to mechanical loading." Ultrasound diagnosis must confirm alteration of tendon macrostructure.
Group II: Bone-patellar tendon-bone (BPTB)Experimental Treatment2 Interventions
This group will have patellar injury confirmed through self-reported surgical history and evidence of ipsilateral BPTB graft harvest on ultrasound.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ultrasound (US)
2015
Completed Phase 4
~40
MRI
2009
Completed Phase 2
~2810

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,223 Previous Clinical Trials
3,168,125 Total Patients Enrolled
Bryan Heiderscheit, PT, PhDPrincipal InvestigatorUniversity of Wisconsin, Madison
Daniel Cobian, DPT, PhDPrincipal InvestigatorUniversity of Wisconsin, Madison
~7 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top